CELC · Celcuity Inc
United States · RS rating 14 · As of 2026-10-14
| Price | 59.90 USD |
|---|---|
| 1-day change | -5.2% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 7 / 11 / 80 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 8 / 6 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -5.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +58.7% |
| Market cap (USD) | $5.5B |